Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This precision-health approach ensures therapy matches individual physiology rather than applying one-size-fits-all protocols
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
This unique three-receptor approach is being studied for its potential effects on body weight regulation, glucose metabolism, appetite control, and energy balance
If gastrointestinal symptoms persist, your doctor may delay dose escalation by at least 4 weeks or reduce the dose from 14 mg to 7 mg if not tolerated
US$ 24.01
US$ 26.16
US$ 26.57
US$ 22.78
